DAFNA Capital Management’s Adicet Bio ACET Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $329K | Sell |
540,000
-60,000
| -10% | -$36.6K | 0.09% | 69 |
|
|
2025
Q1 | $453K | Hold |
600,000
| – | – | 0.13% | 73 |
|
|
2024
Q4 | $577K | Hold |
600,000
| – | – | 0.15% | 71 |
|
|
2024
Q3 | $864K | Hold |
600,000
| – | – | 0.2% | 64 |
|
|
2024
Q2 | $726K | Hold |
600,000
| – | – | 0.17% | 67 |
|
|
2024
Q1 | $1.41M | Buy |
+600,000
| New | +$1.41M | 0.32% | 54 |
|
|
2023
Q4 | – | Sell |
-797,054
| Closed | -$1.09M | – | 77 |
|
|
2023
Q3 | $1.09M | Hold |
797,054
| – | – | 0.34% | 54 |
|
|
2023
Q2 | $1.94M | Hold |
797,054
| – | – | 0.53% | 41 |
|
|
2023
Q1 | $4.59M | Buy |
797,054
+165,500
| +26% | +$953K | 1.38% | 26 |
|
|
2022
Q4 | $5.65M | Sell |
631,554
-304,212
| -33% | -$2.72M | 1.59% | 18 |
|
|
2022
Q3 | $13.3M | Hold |
935,766
| – | – | 3.58% | 7 |
|
|
2022
Q2 | $13.7M | Buy |
935,766
+219,894
| +31% | +$3.21M | 3.72% | 4 |
|
|
2022
Q1 | $14.3M | Sell |
715,872
-17,300
| -2% | -$345K | 3.73% | 5 |
|
|
2021
Q4 | $12.8M | Buy |
733,172
+356,891
| +95% | +$6.24M | 3.22% | 4 |
|
|
2021
Q3 | $2.95M | Hold |
376,281
| – | – | 0.78% | 31 |
|
|
2021
Q2 | $3.87M | Sell |
376,281
-8,796
| -2% | -$90.5K | 0.81% | 31 |
|
|
2021
Q1 | $5.04M | Buy |
385,077
+307,500
| +396% | +$4.02M | 1.2% | 24 |
|
|
2020
Q4 | $1.09M | Buy |
77,577
+10,000
| +15% | +$141K | 0.32% | 57 |
|
|
2020
Q3 | $803K | Buy |
+67,577
| New | +$803K | 0.26% | 59 |
|